Twentyfour Ambulatory Pulse Wave Velocity and Central Augmentation Index in Type 2 Diabetes

Completed

• Conditions: Type 2 Diabetes

• Registration Number: NCT01812811
• Lead Sponsor: University of Aarhus

Brief Summary

The functionality and reproducibility of pulse wave analysis is investigated in 20 type 2 diabetic patients who had two 24 hour measurements performed within one week with the Arteriograph24 equipment.

Detailed Description

Arteriograph24 is a new monitor for measuring ambulatory blood pressure and additional performing brachial cuff based on analysis of a suprasystolic pulse wave.

The study aim to test the feasibility of ambulatory pulse wave analysis every twenty minute (the fraction of missed measurements)and the reprodicility of pulse wave velocity and central augmentation index in type 2 diabetic patients. In addition we will explore the relation between diurnal variation of brachial blood pressure, central blood pressure and pulse wave velocity.

20 type 2 diabetic patients will have 24h ambulatory blood pressure performed twice with an interval of one week.

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2012-09
• Study First Submitted: 2013-03-14
• Study First Submitted QC: 2013-03-14
• Study First Posted: 2013-03-18
• Primary Completion: 2013-07
• Study Completion: 2013-07
• Status Verified: 2013-12
• Last Update Submitted: 2013-12-10
• Last Update Posted: 2013-12-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 22

Inclusion Criteria

• Type 2 diabetes

Read More

Exclusion Criteria

• Atrial fibrillation

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fraction of missed pulse wave analysis	Meaured two times with an interval of one week	Measurements of ambulatory blood pressure and pulse wave analysis is performed every twenty minute. The fraction of missed measurements of pulse wave analysis during day time and night time analysis is the final outcome

Secondary Outcome Measures

Name	Time	Method
Reproducibility of pulse wave analysis parameters	Measured two times with an interval of one week	Reproducibility of pulse wave velocity, Central systolic blood pressure and central augmentation index for 24 hour, day and night

Trial Locations

Locations (1)

Medical department, Diagnostic Center, Regional Hospital Silkeborg; 🇩🇰 Silkeborg, Denmark